| 6.0 |
18.0 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 3.7 |
14.7 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 3.4 |
20.6 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 3.2 |
50.5 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 2.4 |
7.2 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 2.2 |
6.7 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 2.0 |
6.1 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 2.0 |
6.0 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.9 |
5.8 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.7 |
1.7 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.7 |
5.0 |
GO:0038095 |
positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
| 1.6 |
4.8 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 1.6 |
4.7 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 1.5 |
3.0 |
GO:1900453 |
negative regulation of long term synaptic depression(GO:1900453) |
| 1.5 |
1.5 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 1.5 |
1.5 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 1.5 |
2.9 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 1.4 |
5.7 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 1.3 |
2.7 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 1.3 |
5.3 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.3 |
1.3 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 1.2 |
4.9 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 1.2 |
4.8 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 1.1 |
3.4 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.1 |
3.2 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 1.0 |
7.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.0 |
3.1 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.0 |
4.1 |
GO:0034727 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
| 1.0 |
3.0 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.0 |
4.0 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.0 |
3.0 |
GO:1903546 |
receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 1.0 |
2.9 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 1.0 |
13.4 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.9 |
3.7 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.9 |
1.8 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.9 |
0.9 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.9 |
2.7 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.9 |
2.7 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.9 |
5.3 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.8 |
2.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.8 |
2.4 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.8 |
5.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.7 |
2.2 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.7 |
2.1 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.7 |
3.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.7 |
2.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.7 |
1.4 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.7 |
11.0 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.7 |
3.3 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.7 |
7.3 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.7 |
2.6 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.7 |
2.0 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.6 |
1.9 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.6 |
3.1 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.6 |
3.0 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.6 |
7.1 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.6 |
1.2 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.6 |
2.4 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.6 |
2.3 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.6 |
5.8 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.6 |
18.3 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.6 |
1.7 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.5 |
2.7 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.5 |
4.3 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.5 |
2.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.5 |
14.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.5 |
4.6 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.5 |
9.7 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.5 |
0.5 |
GO:0007128 |
M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.5 |
1.5 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.5 |
1.5 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.5 |
1.5 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.5 |
3.9 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.5 |
0.5 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.5 |
2.3 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.5 |
1.4 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.5 |
1.9 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.4 |
3.6 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.4 |
1.8 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.4 |
2.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.4 |
4.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.4 |
1.3 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.4 |
15.9 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.4 |
0.8 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.4 |
1.6 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 |
1.6 |
GO:0061428 |
embryonic heart tube left/right pattern formation(GO:0060971) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 |
1.6 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.4 |
0.8 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.4 |
1.5 |
GO:2000551 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.4 |
8.4 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.4 |
3.1 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.4 |
1.1 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.4 |
3.8 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.4 |
1.8 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.4 |
1.4 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.3 |
0.3 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 |
1.7 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.3 |
3.1 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 |
6.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.3 |
1.0 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.3 |
1.3 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.3 |
1.3 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.3 |
1.3 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.3 |
3.9 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.3 |
1.3 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 |
1.0 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
8.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.3 |
1.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 |
1.3 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.3 |
5.3 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.3 |
2.5 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
1.2 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 |
1.2 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.3 |
0.9 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.3 |
0.9 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.3 |
0.9 |
GO:0032240 |
RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.3 |
1.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 |
0.9 |
GO:2000822 |
regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
| 0.3 |
2.3 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.3 |
0.3 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.3 |
0.6 |
GO:0090325 |
regulation of locomotion involved in locomotory behavior(GO:0090325) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.3 |
2.6 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.3 |
3.9 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.3 |
1.4 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 |
0.8 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.3 |
5.9 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 |
4.0 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.3 |
1.3 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.3 |
2.4 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 |
6.0 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 |
1.0 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.3 |
4.1 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 |
2.8 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.3 |
3.3 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.3 |
3.6 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.3 |
1.0 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.3 |
1.5 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
2.9 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 |
0.7 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.2 |
0.5 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
1.0 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.2 |
2.2 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 0.2 |
4.3 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.2 |
0.7 |
GO:1900041 |
intestinal D-glucose absorption(GO:0001951) negative regulation of interleukin-2 secretion(GO:1900041) terminal web assembly(GO:1902896) |
| 0.2 |
0.7 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 |
0.9 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
2.3 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.2 |
0.9 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.2 |
2.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
3.2 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
4.6 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.2 |
1.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 |
0.7 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
0.9 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
2.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.2 |
2.1 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.2 |
3.8 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.2 |
0.4 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 |
2.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.2 |
1.8 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 |
2.0 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
2.0 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
1.0 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.2 |
1.2 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.2 |
0.6 |
GO:0046671 |
regulation of cellular pH reduction(GO:0032847) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.2 |
4.3 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.2 |
1.4 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 |
0.6 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.2 |
1.2 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
1.5 |
GO:2000074 |
response to redox state(GO:0051775) regulation of type B pancreatic cell development(GO:2000074) |
| 0.2 |
0.9 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.2 |
0.4 |
GO:0072194 |
sensory perception of touch(GO:0050975) kidney smooth muscle tissue development(GO:0072194) |
| 0.2 |
0.4 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.2 |
1.6 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 |
0.5 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
1.4 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.2 |
1.1 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
1.6 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.5 |
GO:1902837 |
amino acid import into cell(GO:1902837) |
| 0.2 |
2.8 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.2 |
6.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.2 |
1.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
1.5 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.2 |
0.5 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
1.5 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
0.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
1.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
0.5 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.2 |
1.0 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.2 |
2.9 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.2 |
0.6 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 |
0.5 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 |
0.8 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
1.3 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.1 |
1.4 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.1 |
1.8 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.4 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.1 |
4.2 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
1.0 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
1.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.8 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.4 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.1 |
1.8 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
1.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.9 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
1.0 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.6 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
0.9 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.6 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 0.1 |
1.5 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.7 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
6.1 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.1 |
0.7 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.8 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.1 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.1 |
2.9 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.1 |
1.2 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.1 |
3.7 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.1 |
1.7 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 |
0.9 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
1.0 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.1 |
0.2 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.1 |
0.3 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 |
0.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.9 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.1 |
1.0 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
1.0 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
4.1 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.1 |
0.5 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.2 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.1 |
1.1 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.5 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
3.1 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.1 |
0.4 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.1 |
5.2 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.1 |
4.6 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
0.1 |
GO:0060214 |
stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) endocardium formation(GO:0060214) |
| 0.1 |
2.2 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.1 |
0.6 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
3.4 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.1 |
0.8 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 |
1.7 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
1.0 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
1.5 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 |
0.6 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.7 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.5 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
3.3 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
0.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.4 |
GO:0043314 |
negative regulation of cellular extravasation(GO:0002692) negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 |
4.8 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.4 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 |
1.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
1.2 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.7 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
2.8 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.8 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.1 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 |
2.1 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.1 |
1.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
3.2 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 |
0.8 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
1.2 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.1 |
GO:0010612 |
regulation of cardiac muscle adaptation(GO:0010612) |
| 0.1 |
0.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
4.2 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
1.1 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
0.2 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.1 |
0.2 |
GO:0044828 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 |
1.7 |
GO:0046854 |
lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 |
5.3 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.1 |
0.3 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 |
0.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.7 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.8 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
1.1 |
GO:0021702 |
cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 |
1.1 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
1.6 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.2 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 |
0.7 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.7 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
1.6 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.6 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.1 |
0.9 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.1 |
0.9 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.3 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.1 |
0.4 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.5 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
1.0 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 |
0.5 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.0 |
1.0 |
GO:0048599 |
oocyte development(GO:0048599) |
| 0.0 |
0.7 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.3 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
1.0 |
GO:0030819 |
positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 |
0.0 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.0 |
0.2 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.0 |
0.4 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
3.7 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.6 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.0 |
0.2 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.0 |
1.0 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.4 |
GO:0060004 |
reflex(GO:0060004) |
| 0.0 |
1.2 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.0 |
0.2 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 |
0.4 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.0 |
0.2 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.0 |
0.7 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.6 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.0 |
1.2 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.1 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 |
0.6 |
GO:1900746 |
regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.0 |
0.5 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.2 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.2 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.0 |
0.7 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.3 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 |
0.7 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
1.5 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.0 |
0.3 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 |
0.3 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.5 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.3 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.0 |
2.1 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.5 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.0 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.0 |
0.2 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
0.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.4 |
GO:0060998 |
regulation of dendritic spine development(GO:0060998) |
| 0.0 |
0.3 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
1.0 |
GO:0045682 |
regulation of epidermis development(GO:0045682) |
| 0.0 |
0.0 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.0 |
0.2 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.1 |
GO:0033129 |
positive regulation of histone phosphorylation(GO:0033129) |
| 0.0 |
0.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.9 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.1 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
1.0 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.4 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.5 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.0 |
0.8 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.4 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.5 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.5 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.3 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.8 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.4 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.2 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.1 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.0 |
1.0 |
GO:0031123 |
RNA 3'-end processing(GO:0031123) |
| 0.0 |
0.9 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.1 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.0 |
0.6 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
| 0.0 |
1.0 |
GO:0015807 |
L-amino acid transport(GO:0015807) |
| 0.0 |
0.4 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 |
0.2 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.1 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.1 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.0 |
0.7 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 |
0.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.9 |
GO:0010951 |
negative regulation of endopeptidase activity(GO:0010951) |
| 0.0 |
0.1 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.0 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |